| HOME >> BIOLOGY >> TECHNOLOGY |
Harvard Medical School Researchers Used Thermo Scientific Dharmacon siRNA to Identify 273 Human Proteins Needed for Reproduction of the Virus that
Causes AIDS
WALTHAM, Mass., Jan. 31 /PRNewswire-FirstCall/ -- Thermo Fisher Scientific Inc., the world leader in serving science, announced today that its RNA-interference (RNAi) technology has enabled a groundbreaking study at Harvard Medical School in Boston, which identified human proteins required for growth of the human immunodeficiency virus (HIV). This research points to potential new targets for treating HIV infection, which causes acquired immune deficiency syndrome (AIDS).
In the study, Harvard Medical School researchers used the Thermo Scientific Dharmacon(R) siGENOME(R) siRNA Library to "silence" more than 21,000 human genes, blocking the proteins they produce. With the help of Harvard's ICCB-Longwood High Throughput Screening Facility, the researchers identified 273 proteins required for HIV reproduction. Only 36 were previously known to be important to HIV.
"This study clearly demonstrates the power of genome-wide RNAi screening in identifying novel drug targets," said Ian Jardine, vice president of global research and development for Thermo Fisher Scientific. "The Harvard Medical School findings dramatically expand the number of potential targets for fighting HIV. It is an exciting discovery that holds promise for new treatments, and we are thrilled that our genome-wide siRNA library enabled this work."
Current HIV therapies target the virus itself, but HIV often mutates to build resistance against those drugs. Drugs targeting host proteins may be significantly less vulnerable to resistance caused by the virus' ability to mutate.
The research team was led by Harvard Medical School (HMS) professor Dr.
Stephen J. Elledge and Dr. Judy Lieberman, HMS professor of pediatrics as
well as an investigator at the Immune Disease Institute and d
'/>"/>
| SOURCE Thermo Fisher Scientific Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc.
2. BioMarin Appoints Dr. Gordon Vehar, Vice President of Research
3. Vasogens Research Published in European Journal of Neuroscience
4. Researchers Pinpoint Best Treatment to Reduce Deadly USA300, MRSA Staph Infections
5. Researchers develop darkest manmade material
6. Clinimetrics Celebrates 20th Anniversary in Contract Research Business
7. Quintiles to Open Clinical Research Office in Wilmington, NC
8. Irving Dark Named Vice President of Cytel Clinical Research Services
9. Boost for Malaria Vaccine Development by Combining Strengths of Dutch and American Researchers
10. VIA Pharmaceuticals Names Rebecca Taub Senior Vice President of Research and Development
11. Collaborative Biosecurity Research Initiative Launched to Target Animal and Public Health Threats Nationally
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |